» Articles » PMID: 8343952

Identification of JAK2 As a Growth Hormone Receptor-associated Tyrosine Kinase

Overview
Journal Cell
Publisher Cell Press
Specialty Cell Biology
Date 1993 Jul 30
PMID 8343952
Citations 198
Authors
Affiliations
Soon will be listed here.
Abstract

Growth hormone receptor (GHR) forms a complex with a tyrosine kinase, suggesting involvement of a ligand-activated tyrosine kinase in intracellular signaling by growth hormone (GH). Here we identify JAK2, a nonreceptor tyrosine kinase, as a GHR-associated tyrosine kinase. Immunological approaches were used to establish GH-dependent complex formation between JAK2 and GHR, activation of JAK2 tyrosine kinase activity, and tyrosyl phosphorylation of both JAK2 and GHR. The JAK2-GHR and JAK2-erythropoietin receptor interactions described here and in the accompanying paper provide a molecular basis for involvement of tyrosyl phosphorylation in physiological responses to these ligands and suggest a shared signaling mechanism among members of the cytokine/hematopoietin receptor family.

Citing Articles

SOCS2 inhibits the tumorigenesis of GISTs and increases the sensitivity of GISTs to imatinib by suppression of KIT activation.

Zhang L, Xiao K, Zhang S, Zhao S, Liu Z, Wang M Sci Rep. 2025; 15(1):4779.

PMID: 39922931 PMC: 11807132. DOI: 10.1038/s41598-025-89477-0.


Hemophagocytic lymphohistiocytosis: current treatment advances, emerging targeted therapy and underlying mechanisms.

Wu Y, Sun X, Kang K, Yang Y, Li H, Zhao A J Hematol Oncol. 2024; 17(1):106.

PMID: 39511607 PMC: 11542428. DOI: 10.1186/s13045-024-01621-x.


2022 Cannon lecture: an ode to signal transduction: how the growth hormone pathway revealed insight into height, malignancy, and obesity.

Carter-Su C, Argetsinger L, Svezhova N Am J Physiol Endocrinol Metab. 2023; 325(5):E425-E437.

PMID: 37672248 PMC: 10874654. DOI: 10.1152/ajpendo.00265.2023.


Role of Estrogen and Estrogen Receptor in GH-Secreting Adenomas.

Voltan G, Mazzeo P, Regazzo D, Scaroni C, Ceccato F Int J Mol Sci. 2023; 24(12).

PMID: 37373068 PMC: 10297914. DOI: 10.3390/ijms24129920.


Exploring the Therapeutic Potential of Targeting GH and IGF-1 in the Management of Obesity: Insights from the Interplay between These Hormones and Metabolism.

Al-Samerria S, Radovick S Int J Mol Sci. 2023; 24(11).

PMID: 37298507 PMC: 10253584. DOI: 10.3390/ijms24119556.